PMCA4 inhibition does not affect cardiac remodelling following myocardial infarction, but may reduce susceptibility to arrhythmia
Abstract Ischaemic heart disease is the world’s leading cause of mortality. Survival rates from acute myocardial infarction (MI) have improved in recent years; however, this has led to an increase in the prevalence of heart failure (HF) due to chronic remodelling of the infarcted myocardium, for whi...
Main Authors: | Nicholas Stafford, Min Zi, Florence Baudoin, Tamer M. A. Mohamed, Sukhpal Prehar, Daria De Giorgio, Elizabeth J. Cartwright, Roberto Latini, Ludwig Neyses, Delvac Oceandy |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2021-01-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-021-81170-2 |
Similar Items
-
Cardiac hypertrophy or failure? - A systematic evaluation of the transverse aortic constriction model in C57BL/6NTac and C57BL/6J substrains
by: Min Zi, et al.
Published: (2019-12-01) -
The plasma membrane calcium ATPase 4 signalling in cardiac fibroblasts mediates cardiomyocyte hypertrophy
by: Tamer M. A. Mohamed, et al.
Published: (2016-03-01) -
Expression of foetal gene Pontin is essential in protecting heart against pathological remodelling and cardiomyopathy
by: Bayu Lestari, et al.
Published: (2025-02-01) -
Optimisation and Validation of a High Throughput Screening Compatible Assay to Identify Inhibitors of the Plasma Membrane Calcium ATPase Pump - a Novel Therapeutic Target for Contraception and Malaria
by: Tamer M A Mohamed, et al.
Published: (2013-05-01) -
Plasma membrane calcium pump (PMCA4)-neuronal nitric-oxide synthase complex regulates cardiac contractility through modulation of a compartmentalized cyclic nucleotide microdomain.
by: Mohamed, T, et al.
Published: (2011)